img

Global RNAi Technology Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global RNAi Technology Market Insights, Forecast to 2034

RNA interference is a relatively new concept in the field of medicine. It is a process in which the ribonucleic acid inhibits translation or gene expression by converting single-stranded mRNA to double stranded RNA, thereby neutralizing the target nucleic acids.
Market Analysis and InsightsGlobal RNAi Technology Market
Global RNAi Technology market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, RNAi Technology industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.97%, including software, hardware and services.
Report Covers
This report presents an overview of global RNAi Technology market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global RNAi Technology market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Alnylam Pharmaceuticals
Dicerna Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc.
Arbutus Biopharma
Benitec Biopharma
Calando
Silence Therapeutics
Gotham Therapeutics
Segment by Type
Cancer
Liver Disorders
Respiratory Disorders
Neurological Disorders
Autoimmune Disorders
Others

Segment by Application


Drug Discovery & Development
Therapeutics
Drug Delivery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, RNAi Technology introduction, etc. RNAi Technology Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of RNAi Technology
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNAi Technology Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Cancer
1.2.3 Liver Disorders
1.2.4 Respiratory Disorders
1.2.5 Neurological Disorders
1.2.6 Autoimmune Disorders
1.2.7 Others
1.3 Market by Application
1.3.1 Global RNAi Technology Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Drug Discovery & Development
1.3.3 Therapeutics
1.3.4 Drug Delivery
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNAi Technology Market Perspective (2018-2033)
2.2 Global RNAi Technology Growth Trends by Region
2.2.1 RNAi Technology Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 RNAi Technology Historic Market Size by Region (2018-2023)
2.2.3 RNAi Technology Forecasted Market Size by Region (2024-2033)
2.3 RNAi Technology Market Dynamics
2.3.1 RNAi Technology Industry Trends
2.3.2 RNAi Technology Market Drivers
2.3.3 RNAi Technology Market Challenges
2.3.4 RNAi Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue RNAi Technology by Players
3.1.1 Global RNAi Technology Revenue by Players (2018-2023)
3.1.2 Global RNAi Technology Revenue Market Share by Players (2018-2023)
3.2 Global RNAi Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of RNAi Technology, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global RNAi Technology Market Concentration Ratio
3.4.1 Global RNAi Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNAi Technology Revenue in 2022
3.5 Global Key Players of RNAi Technology Head office and Area Served
3.6 Global Key Players of RNAi Technology, Product and Application
3.7 Global Key Players of RNAi Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 RNAi Technology Breakdown Data by Type
4.1 Global RNAi Technology Historic Market Size by Type (2018-2023)
4.2 Global RNAi Technology Forecasted Market Size by Type (2024-2033)
5 RNAi Technology Breakdown Data by Application
5.1 Global RNAi Technology Historic Market Size by Application (2018-2023)
5.2 Global RNAi Technology Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America RNAi Technology Market Size (2018-2033)
6.2 North America RNAi Technology Market Size by Type
6.2.1 North America RNAi Technology Market Size by Type (2018-2023)
6.2.2 North America RNAi Technology Market Size by Type (2024-2033)
6.2.3 North America RNAi Technology Market Share by Type (2018-2033)
6.3 North America RNAi Technology Market Size by Application
6.3.1 North America RNAi Technology Market Size by Application (2018-2023)
6.3.2 North America RNAi Technology Market Size by Application (2024-2033)
6.3.3 North America RNAi Technology Market Share by Application (2018-2033)
6.4 North America RNAi Technology Market Size by Country
6.4.1 North America RNAi Technology Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America RNAi Technology Market Size by Country (2018-2023)
6.4.3 North America RNAi Technology Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe RNAi Technology Market Size (2018-2033)
7.2 Europe RNAi Technology Market Size by Type
7.2.1 Europe RNAi Technology Market Size by Type (2018-2023)
7.2.2 Europe RNAi Technology Market Size by Type (2024-2033)
7.2.3 Europe RNAi Technology Market Share by Type (2018-2033)
7.3 Europe RNAi Technology Market Size by Application
7.3.1 Europe RNAi Technology Market Size by Application (2018-2023)
7.3.2 Europe RNAi Technology Market Size by Application (2024-2033)
7.3.3 Europe RNAi Technology Market Share by Application (2018-2033)
7.4 Europe RNAi Technology Market Size by Country
7.4.1 Europe RNAi Technology Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe RNAi Technology Market Size by Country (2018-2023)
7.4.3 Europe RNAi Technology Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China RNAi Technology Market Size (2018-2033)
8.2 China RNAi Technology Market Size by Type
8.2.1 China RNAi Technology Market Size by Type (2018-2023)
8.2.2 China RNAi Technology Market Size by Type (2024-2033)
8.2.3 China RNAi Technology Market Share by Type (2018-2033)
8.3 China RNAi Technology Market Size by Application
8.3.1 China RNAi Technology Market Size by Application (2018-2023)
8.3.2 China RNAi Technology Market Size by Application (2024-2033)
8.3.3 China RNAi Technology Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia RNAi Technology Market Size (2018-2033)
9.2 Asia RNAi Technology Market Size by Type
9.2.1 Asia RNAi Technology Market Size by Type (2018-2023)
9.2.2 Asia RNAi Technology Market Size by Type (2024-2033)
9.2.3 Asia RNAi Technology Market Share by Type (2018-2033)
9.3 Asia RNAi Technology Market Size by Application
9.3.1 Asia RNAi Technology Market Size by Application (2018-2023)
9.3.2 Asia RNAi Technology Market Size by Application (2024-2033)
9.3.3 Asia RNAi Technology Market Share by Application (2018-2033)
9.4 Asia RNAi Technology Market Size by Region
9.4.1 Asia RNAi Technology Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia RNAi Technology Market Size by Region (2018-2023)
9.4.3 Asia RNAi Technology Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America RNAi Technology Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America RNAi Technology Market Size by Type
10.2.1 Middle East, Africa, and Latin America RNAi Technology Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America RNAi Technology Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America RNAi Technology Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America RNAi Technology Market Size by Application
10.3.1 Middle East, Africa, and Latin America RNAi Technology Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America RNAi Technology Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America RNAi Technology Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America RNAi Technology Market Size by Country
10.4.1 Middle East, Africa, and Latin America RNAi Technology Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America RNAi Technology Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America RNAi Technology Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Details
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals RNAi Technology Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in RNAi Technology Business (2018-2023)
11.1.5 Alnylam Pharmaceuticals Recent Developments
11.2 Dicerna Pharmaceuticals, Inc.
11.2.1 Dicerna Pharmaceuticals, Inc. Company Details
11.2.2 Dicerna Pharmaceuticals, Inc. Business Overview
11.2.3 Dicerna Pharmaceuticals, Inc. RNAi Technology Introduction
11.2.4 Dicerna Pharmaceuticals, Inc. Revenue in RNAi Technology Business (2018-2023)
11.2.5 Dicerna Pharmaceuticals, Inc. Recent Developments
11.3 Arrowhead Pharmaceuticals, Inc.
11.3.1 Arrowhead Pharmaceuticals, Inc. Company Details
11.3.2 Arrowhead Pharmaceuticals, Inc. Business Overview
11.3.3 Arrowhead Pharmaceuticals, Inc. RNAi Technology Introduction
11.3.4 Arrowhead Pharmaceuticals, Inc. Revenue in RNAi Technology Business (2018-2023)
11.3.5 Arrowhead Pharmaceuticals, Inc. Recent Developments
11.4 Ionis Pharmaceuticals, Inc.
11.4.1 Ionis Pharmaceuticals, Inc. Company Details
11.4.2 Ionis Pharmaceuticals, Inc. Business Overview
11.4.3 Ionis Pharmaceuticals, Inc. RNAi Technology Introduction
11.4.4 Ionis Pharmaceuticals, Inc. Revenue in RNAi Technology Business (2018-2023)
11.4.5 Ionis Pharmaceuticals, Inc. Recent Developments
11.5 Quark Pharmaceuticals, Inc.
11.5.1 Quark Pharmaceuticals, Inc. Company Details
11.5.2 Quark Pharmaceuticals, Inc. Business Overview
11.5.3 Quark Pharmaceuticals, Inc. RNAi Technology Introduction
11.5.4 Quark Pharmaceuticals, Inc. Revenue in RNAi Technology Business (2018-2023)
11.5.5 Quark Pharmaceuticals, Inc. Recent Developments
11.6 Arbutus Biopharma
11.6.1 Arbutus Biopharma Company Details
11.6.2 Arbutus Biopharma Business Overview
11.6.3 Arbutus Biopharma RNAi Technology Introduction
11.6.4 Arbutus Biopharma Revenue in RNAi Technology Business (2018-2023)
11.6.5 Arbutus Biopharma Recent Developments
11.7 Benitec Biopharma
11.7.1 Benitec Biopharma Company Details
11.7.2 Benitec Biopharma Business Overview
11.7.3 Benitec Biopharma RNAi Technology Introduction
11.7.4 Benitec Biopharma Revenue in RNAi Technology Business (2018-2023)
11.7.5 Benitec Biopharma Recent Developments
11.8 Calando
11.8.1 Calando Company Details
11.8.2 Calando Business Overview
11.8.3 Calando RNAi Technology Introduction
11.8.4 Calando Revenue in RNAi Technology Business (2018-2023)
11.8.5 Calando Recent Developments
11.9 Silence Therapeutics
11.9.1 Silence Therapeutics Company Details
11.9.2 Silence Therapeutics Business Overview
11.9.3 Silence Therapeutics RNAi Technology Introduction
11.9.4 Silence Therapeutics Revenue in RNAi Technology Business (2018-2023)
11.9.5 Silence Therapeutics Recent Developments
11.10 Gotham Therapeutics
11.10.1 Gotham Therapeutics Company Details
11.10.2 Gotham Therapeutics Business Overview
11.10.3 Gotham Therapeutics RNAi Technology Introduction
11.10.4 Gotham Therapeutics Revenue in RNAi Technology Business (2018-2023)
11.10.5 Gotham Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global RNAi Technology Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Cancer
Table 3. Key Players of Liver Disorders
Table 4. Key Players of Respiratory Disorders
Table 5. Key Players of Neurological Disorders
Table 6. Key Players of Autoimmune Disorders
Table 7. Key Players of Others
Table 8. Global RNAi Technology Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 9. Global RNAi Technology Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global RNAi Technology Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global RNAi Technology Market Share by Region (2018-2023)
Table 12. Global RNAi Technology Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global RNAi Technology Market Share by Region (2024-2033)
Table 14. RNAi Technology Market Trends
Table 15. RNAi Technology Market Drivers
Table 16. RNAi Technology Market Challenges
Table 17. RNAi Technology Market Restraints
Table 18. Global RNAi Technology Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global RNAi Technology Revenue Share by Players (2018-2023)
Table 20. Global Top RNAi Technology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Technology as of 2022)
Table 21. Global RNAi Technology Industry Ranking 2021 VS 2022 VS 2023
Table 22. Global 5 Largest Players Market Share by RNAi Technology Revenue (CR5 and HHI) & (2018-2023)
Table 23. Global Key Players of RNAi Technology, Headquarters and Area Served
Table 24. Global Key Players of RNAi Technology, Product and Application
Table 25. Global Key Players of RNAi Technology, Product and Application
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global RNAi Technology Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global RNAi Technology Revenue Market Share by Type (2018-2023)
Table 29. Global RNAi Technology Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global RNAi Technology Revenue Market Share by Type (2024-2033)
Table 31. Global RNAi Technology Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global RNAi Technology Revenue Share by Application (2018-2023)
Table 33. Global RNAi Technology Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global RNAi Technology Revenue Share by Application (2024-2033)
Table 35. North America RNAi Technology Market Size by Type (2018-2023) & (US$ Million)
Table 36. North America RNAi Technology Market Size by Type (2024-2033) & (US$ Million)
Table 37. North America RNAi Technology Market Size by Application (2018-2023) & (US$ Million)
Table 38. North America RNAi Technology Market Size by Application (2024-2033) & (US$ Million)
Table 39. North America RNAi Technology Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. North America RNAi Technology Market Size by Country (2018-2023) & (US$ Million)
Table 41. North America RNAi Technology Market Size by Country (2024-2033) & (US$ Million)
Table 42. Europe RNAi Technology Market Size by Type (2018-2023) & (US$ Million)
Table 43. Europe RNAi Technology Market Size by Type (2024-2033) & (US$ Million)
Table 44. Europe RNAi Technology Market Size by Application (2018-2023) & (US$ Million)
Table 45. Europe RNAi Technology Market Size by Application (2024-2033) & (US$ Million)
Table 46. Europe RNAi Technology Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Europe RNAi Technology Market Size by Country (2018-2023) & (US$ Million)
Table 48. Europe RNAi Technology Market Size by Country (2024-2033) & (US$ Million)
Table 49. China RNAi Technology Market Size by Type (2018-2023) & (US$ Million)
Table 50. China RNAi Technology Market Size by Type (2024-2033) & (US$ Million)
Table 51. China RNAi Technology Market Size by Application (2018-2023) & (US$ Million)
Table 52. China RNAi Technology Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia RNAi Technology Market Size by Type (2018-2023) & (US$ Million)
Table 54. Asia RNAi Technology Market Size by Type (2024-2033) & (US$ Million)
Table 55. Asia RNAi Technology Market Size by Application (2018-2023) & (US$ Million)
Table 56. Asia RNAi Technology Market Size by Application (2024-2033) & (US$ Million)
Table 57. Asia RNAi Technology Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 58. Asia RNAi Technology Market Size by Region (2018-2023) & (US$ Million)
Table 59. Asia RNAi Technology Market Size by Region (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America RNAi Technology Market Size by Type (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America RNAi Technology Market Size by Type (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America RNAi Technology Market Size by Application (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America RNAi Technology Market Size by Application (2024-2033) & (US$ Million)
Table 64. Middle East, Africa, and Latin America RNAi Technology Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 65. Middle East, Africa, and Latin America RNAi Technology Market Size by Country (2018-2023) & (US$ Million)
Table 66. Middle East, Africa, and Latin America RNAi Technology Market Size by Country (2024-2033) & (US$ Million)
Table 67. Alnylam Pharmaceuticals Company Details
Table 68. Alnylam Pharmaceuticals Business Overview
Table 69. Alnylam Pharmaceuticals RNAi Technology Product
Table 70. Alnylam Pharmaceuticals Revenue in RNAi Technology Business (2018-2023) & (US$ Million)
Table 71. Alnylam Pharmaceuticals Recent Developments
Table 72. Dicerna Pharmaceuticals, Inc. Company Details
Table 73. Dicerna Pharmaceuticals, Inc. Business Overview
Table 74. Dicerna Pharmaceuticals, Inc. RNAi Technology Product
Table 75. Dicerna Pharmaceuticals, Inc. Revenue in RNAi Technology Business (2018-2023) & (US$ Million)
Table 76. Dicerna Pharmaceuticals, Inc. Recent Developments
Table 77. Arrowhead Pharmaceuticals, Inc. Company Details
Table 78. Arrowhead Pharmaceuticals, Inc. Business Overview
Table 79. Arrowhead Pharmaceuticals, Inc. RNAi Technology Product
Table 80. Arrowhead Pharmaceuticals, Inc. Revenue in RNAi Technology Business (2018-2023) & (US$ Million)
Table 81. Arrowhead Pharmaceuticals, Inc. Recent Developments
Table 82. Ionis Pharmaceuticals, Inc. Company Details
Table 83. Ionis Pharmaceuticals, Inc. Business Overview
Table 84. Ionis Pharmaceuticals, Inc. RNAi Technology Product
Table 85. Ionis Pharmaceuticals, Inc. Revenue in RNAi Technology Business (2018-2023) & (US$ Million)
Table 86. Ionis Pharmaceuticals, Inc. Recent Developments
Table 87. Quark Pharmaceuticals, Inc. Company Details
Table 88. Quark Pharmaceuticals, Inc. Business Overview
Table 89. Quark Pharmaceuticals, Inc. RNAi Technology Product
Table 90. Quark Pharmaceuticals, Inc. Revenue in RNAi Technology Business (2018-2023) & (US$ Million)
Table 91. Quark Pharmaceuticals, Inc. Recent Developments
Table 92. Arbutus Biopharma Company Details
Table 93. Arbutus Biopharma Business Overview
Table 94. Arbutus Biopharma RNAi Technology Product
Table 95. Arbutus Biopharma Revenue in RNAi Technology Business (2018-2023) & (US$ Million)
Table 96. Arbutus Biopharma Recent Developments
Table 97. Benitec Biopharma Company Details
Table 98. Benitec Biopharma Business Overview
Table 99. Benitec Biopharma RNAi Technology Product
Table 100. Benitec Biopharma Revenue in RNAi Technology Business (2018-2023) & (US$ Million)
Table 101. Benitec Biopharma Recent Developments
Table 102. Calando Company Details
Table 103. Calando Business Overview
Table 104. Calando RNAi Technology Product
Table 105. Calando Revenue in RNAi Technology Business (2018-2023) & (US$ Million)
Table 106. Calando Recent Developments
Table 107. Silence Therapeutics Company Details
Table 108. Silence Therapeutics Business Overview
Table 109. Silence Therapeutics RNAi Technology Product
Table 110. Silence Therapeutics Revenue in RNAi Technology Business (2018-2023) & (US$ Million)
Table 111. Silence Therapeutics Recent Developments
Table 112. Gotham Therapeutics Company Details
Table 113. Gotham Therapeutics Business Overview
Table 114. Gotham Therapeutics RNAi Technology Product
Table 115. Gotham Therapeutics Revenue in RNAi Technology Business (2018-2023) & (US$ Million)
Table 116. Gotham Therapeutics Recent Developments
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNAi Technology Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global RNAi Technology Market Share by Type: 2022 VS 2033
Figure 3. Cancer Features
Figure 4. Liver Disorders Features
Figure 5. Respiratory Disorders Features
Figure 6. Neurological Disorders Features
Figure 7. Autoimmune Disorders Features
Figure 8. Others Features
Figure 9. Global RNAi Technology Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 10. Global RNAi Technology Market Share by Application: 2022 VS 2033
Figure 11. Drug Discovery & Development Case Studies
Figure 12. Therapeutics Case Studies
Figure 13. Drug Delivery Case Studies
Figure 14. Others Case Studies
Figure 15. RNAi Technology Report Years Considered
Figure 16. Global RNAi Technology Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global RNAi Technology Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global RNAi Technology Market Share by Region: 2022 VS 2033
Figure 19. Global RNAi Technology Market Share by Players in 2022
Figure 20. Global Top RNAi Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Technology as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by RNAi Technology Revenue in 2022
Figure 22. North America RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America RNAi Technology Market Share by Type (2018-2033)
Figure 24. North America RNAi Technology Market Share by Application (2018-2033)
Figure 25. North America RNAi Technology Market Share by Country (2018-2033)
Figure 26. United States RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Canada RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe RNAi Technology Market Size YoY (2018-2033) & (US$ Million)
Figure 29. Europe RNAi Technology Market Share by Type (2018-2033)
Figure 30. Europe RNAi Technology Market Share by Application (2018-2033)
Figure 31. Europe RNAi Technology Market Share by Country (2018-2033)
Figure 32. Germany RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. France RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. U.K. RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Italy RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Russia RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Nordic Countries RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. China RNAi Technology Market Size YoY (2018-2033) & (US$ Million)
Figure 39. China RNAi Technology Market Share by Type (2018-2033)
Figure 40. China RNAi Technology Market Share by Application (2018-2033)
Figure 41. Asia RNAi Technology Market Size YoY (2018-2033) & (US$ Million)
Figure 42. Asia RNAi Technology Market Share by Type (2018-2033)
Figure 43. Asia RNAi Technology Market Share by Application (2018-2033)
Figure 44. Asia RNAi Technology Market Share by Region (2018-2033)
Figure 45. Japan RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. South Korea RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. China Taiwan RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Southeast Asia RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. India RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Australia RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America RNAi Technology Market Size YoY (2018-2033) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America RNAi Technology Market Share by Type (2018-2033)
Figure 53. Middle East, Africa, and Latin America RNAi Technology Market Share by Application (2018-2033)
Figure 54. Middle East, Africa, and Latin America RNAi Technology Market Share by Country (2018-2033)
Figure 55. Brazil RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Mexico RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Turkey RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Saudi Arabia RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Israel RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. GCC Countries RNAi Technology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 61. Alnylam Pharmaceuticals Revenue Growth Rate in RNAi Technology Business (2018-2023)
Figure 62. Dicerna Pharmaceuticals, Inc. Revenue Growth Rate in RNAi Technology Business (2018-2023)
Figure 63. Arrowhead Pharmaceuticals, Inc. Revenue Growth Rate in RNAi Technology Business (2018-2023)
Figure 64. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in RNAi Technology Business (2018-2023)
Figure 65. Quark Pharmaceuticals, Inc. Revenue Growth Rate in RNAi Technology Business (2018-2023)
Figure 66. Arbutus Biopharma Revenue Growth Rate in RNAi Technology Business (2018-2023)
Figure 67. Benitec Biopharma Revenue Growth Rate in RNAi Technology Business (2018-2023)
Figure 68. Calando Revenue Growth Rate in RNAi Technology Business (2018-2023)
Figure 69. Silence Therapeutics Revenue Growth Rate in RNAi Technology Business (2018-2023)
Figure 70. Gotham Therapeutics Revenue Growth Rate in RNAi Technology Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries